| 发明名称 |
ANTI-PD-L1 COMBINATIONS FOR TREATING TUMORS |
| 摘要 |
The present invention relates to therapeutic combinations and methods for treating cancers using combination therapy. |
| 申请公布号 |
US2017114137(A1) |
申请公布日期 |
2017.04.27 |
| 申请号 |
US201715401843 |
申请日期 |
2017.01.09 |
| 申请人 |
BIRDIE BIOPHARMACEUTICALS, INC. |
发明人 |
Li Lixin |
| 分类号 |
C07K16/28;A61K31/4745;C07K16/30;A61K39/395;A61K45/06 |
主分类号 |
C07K16/28 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A combination, comprising:
(i) an effective amount of a PD-L/PD-1 Axis antagonist; and (ii) an effective amount of an immunotherapeutic that is capable of activating a human plasmacytoid dendritic cell, myeloid dendritic cell, or NK cell, or a combination thereof. |
| 地址 |
Grand Cayman KY |
